Friend murine leukemia virus (F-MuLV) induces erythroleukemia when inoculated into newborn BALB/c or NIH/Swiss mice. We have molecularly cloned F-MuLV host cell DNA junction fragments from an erythroleukemia cell line induced by F-MuLV to identify cellular genes involved in the leukemogenic process. One particular proviral integration site, Fli-1, is rearranged in 75% (9/12) of independently isolated erythroleukemia cell lines derived from either BALB/c or NIH/Swiss mice inoculated at birth with F-MuLV. Other hematopoietic neoplasms induced by F-MuLV, including myeloid (granulocytic) and lymphoid tumors, did not show rearrangements of the Fli-) locus. Similarly, none of 35 erythroleukemia cell lines induced by the Friend virus complexes (FV-A and FV-P) was rearranged at the Fli-1 locus. In contrast, no rearrangements were detected at the Sfpi-1 locus, a preferred site of integration in either FV-P-or FV-A-induced leukemias. Using recombinant inbred mice, the Fli-) locus was situated on mouse chromosome 9 close to the cellular protooncogene c-ets-1 . DNA and RNA analysis suggests, however, that Fli-1 is different from ets-). Thus, Fli-1 appears to define a distinct locus specifically involved in the induction of erythroid leukemias by F-MuLV.
NIH/Swiss mice inoculated at birth with F-MuLV. Other hematopoietic neoplasms induced by F-MuLV, including myeloid (granulocytic) and lymphoid tumors, did not show rearrangements of the Fli-) locus. Similarly, none of 35 erythroleukemia cell lines induced by the Friend virus complexes (FV-A and FV-P) was rearranged at the Fli-1 locus. In contrast, no rearrangements were detected at the Sfpi-1 locus, a preferred site of integration in either FV-P-or FV-A-induced leukemias. Using recombinant inbred mice, the Fli-) locus was situated on mouse chromosome 9 close to the cellular protooncogene c-ets-1 . DNA and RNA analysis suggests, however, that Fli-1 is different from ets-). Thus, Fli-1 appears to define a distinct locus specifically involved in the induction of erythroid leukemias by F-MuLV.
The induction of malignancies by retroviruses lacking an oncogene frequently involves the activation of cellular genes by retroviral integration. The spectrum of cellular genes that serve as targets for activation includes, but is not restricted to, protooncogenes initially identified as the cellular counterparts of viral oncogenes present in the genomes of acutely transforming retroviruses. For example, the induction of bursal lymphomas in chickens by avian leukosis virus (ALV) commonly involves the activation of the c-myc protooncogene as a result of insertional activation of ALV (1) . Activation of the c-myc protooncogene has also been described in T-cell lymphomas induced in mice by murine leukemia viruses (MuLVs; refs. 2 and 3). Other cellular protooncogenes, which are activated by slowly transforming retroviruses, include c-erbB (4), c-fms (5) , and c-myb (6, 7) . The slowly transforming retroviruses also appear to integrate near, and thereby activate, a large number of additional cellular genes that have not been previously identified as the cellular counterparts of viral onc genes (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Thus, protooncogenes activated by a retroviral insertion event can be tagged and isolated by characterizing common integration sites in retrovirus-induced malignancies.
We are interested in understanding the molecular events responsible for the progression from the early preleukemic stage of Friend disease to the late malignant stage induced by the Friend murine leukemia virus (F-MuLV) complex. The early stage of Friend leukemia is characterized by the rapid proliferation and terminal differentiation of a large number of nontumorigenic erythroid cells. The late stage is associated with the emergence of a small number of tumorigenic clones capable of indefinite growth in appropriate host or in cell culture (18, 19) . Both polycythemia-and anemia-inducing strains of Friend virus (FV-P and FV-A, respectively) are complexes of a replication-defective spleen focus-forming virus (SFFV-P and SFFV-A) and a replication-competent F-MuLV. Both FV-P and FV-A induce multistage erythroleukemias when inoculated into susceptible newborn or adult mice. However, F-MuLV induces a variety of hematopoietic neoplasms, including erythroblastosis, lymphomas, and myeloblastic leukemias, when injected into appropriate strains of newborn susceptible mice (16) .
We have previously shown that inactivation of the cellular p53 gene is a common, if not obligate, step in leukemic transformation induced by either F-MuLV or FV-P and FV-A (20, 21) . Such observations have led to the conclusion that p53 is a tumor suppressor gene whose inactivation is involved in mouse erythroleukemia and perhaps a wide range of other tumors in mice (22) and in humans (23) . Inactivation of the p53 gene does not appear, however, to be sufficient to induce the late stage of Friend erythroleukemia. Moreau-Gachelin et al. (17) have shown that another cellular gene, originally termed Spi-J and now designated Sfpi-J (SFFV proviral integration 1), is activated by proviral insertion in leukemias induced by FV-P. Thus, the disease induced by Friend virus complex involves both the activation of a cellular gene and the inactivation of a tumor suppressor gene. Because Sfpi-J does not appear to be involved in the erythroleukemias induced by F-MuLV (17), we examined the sites of F-MuLV integration in a number of independent erythroleukemia cell clones induced by that virus. Here, we report a common integration site for F-MuLV, named Fli-l (Friend leukemia integration 1), which is involved in a very high proportion of erythroleukemias induced by F-MuLV but not FV-P or FV-A.
MATERIALS AND METHODS
Cell Lines. The erythroleukemia cell lines CB3 and CB7 were derived from methylcellulose colonies from the greatly enlarged spleens of BALB/c mice injected at birth with F-MuLV (24) . TP3 and TP1 are two independent cell lines derived from the spleens of NIH/Swiss mice injected at birth with F-MuLV and were a gift of A. Oliff (25) tTo whom reprint requests should be addressed.
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obtained from C57BL/6 mice inoculated as neonates with F-MuLV (16) was generously provided by J. Silver (National Institutes of Health, Bethesda, MD). The erythroleukemia cell lines DP20-B11, DP28-9, DP27-17, DP25-16, DP23-31, DA24-27, DA22-C3, and DA26-1 were derived from methylcellulose colonies of spleen cells from DBA/2J adult mice injected with FV-P and FV-A, as described (26) . Cells were maintained in alpha minimum essential medium (a-MEM) supplemented with 10% fetal calf serum.
Molecular Cloning. High molecular weight DNA from the CB3 cell line was partially digested with EcoRI and ligated to the EcoRI arms of the bacteriophage vector EMBL-4 (27) . Phage plaques were screened with 32P-labeled ecotropic envelope-specific probe from F-MuLV, as described (26) and as shown in Fig. 3 . After three cycles of phage purification, the inserted fragments were subcloned into plasmid pUC18.
Tumor DNA and Molecular Hybridization. High molecular weight DNA was isolated by a modification of the proteinase K phenol/chloroform method of Gross-Bellard et al. (28) , as described (29) . DNA was digested with restriction enzymes and electrophoresed on agarose gels. The DNA was aciddepurinated before denaturation and transferred to nitrocellulose (30) . The filters were hybridized with 2 x 106 cpm of nick-translated probe per ml of hybridization mixture that contained 50% formamide, 10% dextran sulfate, 1.5x SSC (lx SSC = 0.15 M NaCl/0.015 M sodium citrate, pH 7), 5x Denhardt's solution (1 x Denhardt's solution = 0.02% bovine serum albumin/0.02% Ficoll/0.02% polyvinylpyrrolidone), and denatured salmon sperm DNA (100 mg/ml) at 42°C (31) . The filters were washed with O.lx SSC and 0.1% SDS at 650C.
Chromosome Mapping. A HincII restriction fragment length polymorphism was defined for the Fli-J B2 probe (see 
RESULTS
Identification and Isolation of a Common Proviral Integration Site (Fli-l) in F-MuLV-Induced Erythroleukemia Cells. To test the possibility that the induction of the late stage of erythroleukemia by F-MuLV requires activation of a specific cellular gene by proviral integration, we analyzed four FMuLV-induced erythroid cell lines by Southern blot hybridization with an envelope-specific probe derived from FMuLV. Under stringent hybridization conditions, this probe detects F-MuLV proviruses and only very weakly hybridizes to endogenous retroviral genomes present in the mouse genome. DNA obtained from the erythroleukemia cell lines CB3, CB7, TP3, and TP1 was digested with EcoRI, an enzyme that cuts once within the F-MuLV genome. Thus, the bands observed after hybridization represent tumor-specific virus-cellular DNA junction fragments and the number of bands should correspond to the number of F-MuLV proviruses integrated in each tumor clone. As shown in Fig. 1 , two of four F-MuLV proviruses were detected in each of the four cell lines examined.
To isolate these viral integration sites, genomic DNA from the cell line CB3 was partially digested with EcoRI, and size-selected (15-20 kbp) DNA was cloned into the A phage EMBL-4. The library was then screened with the F-MuLV env probe shown in Fig. 3 . Twelve positive phage plaques were identified and isolated for further characterization. A combination of restriction mapping and hybridization analysis revealed that all four junction fragments in the CB3 cell line shown in Fig. 1 had been cloned (the lower 5.6-kbp band is actually a doublet of two proviruses). Flanking cellular DNA sequences were subcloned into the plasmid pUC18 and used as probes to determine whether these loci represent common F-MuLV integration sites. A 1.6-kbp EcoRI cellular sequence adjacent to the 5.6-kbp EcoRI junction fragment ( Fig. 1 ) in the CB3 cell line (probe B2 in Fig. 3 ) revealed rearrangements in all four F-MuLV-induced erythroleukemia cell lines used in our initial search for common integration sites (Fig. 2) . Probe B2 hybridized to a 25-kbp EcoRV DNA fragment in normal BALB/c and NIH 3T3 mouse DNA (lanes 3 and 6, respectively). In contrast, this probe detected novel DNA fragments ranging in size from 6.5 to 7.5 kbp in the F-MuLV-induced erythroid cell lines CB3, CB7, TP1, and TP3 (lanes 1, 2, 4, and 5).
To determine whether the locus detected with the B2 probe was rearranged in erythroleukemia cell lines induced by FV-P or FV-A, we analyzed the DNA of 35 such cell lines by digestion with EcoRV. None of these lines contained rearrangement within the 25-kbp DNA fragment detected with the B2 probe in normal cells. Two of the cell lines analyzed, DP28-9 (induced by FV-P) and DA24-27 (induced by FV-A) are shown as examples in Fig. 2 (lanes 7 and 8) . These results indicate that the locus adjacent to F-MuLV, as detected by the B2 probe, is rearranged in 4/4 F-MuLV-induced eryth- probe (shown in Fig. 3 ). HindIl-digested A DNA was used as a marker to estimate the size of the hybridized bands. Lanes: 1, CB3; 2, CB7; 3, BALB/c liver; 4, TP3; 5, TP1; 6, NIH 3T3; 7, DP28-9; 8, DA24-27; 9, DBA/2J liver.
Genetics
Characterization of the Fli-) Locus in DNA from Normal and Leukemic Cells. To characterize the Fli-i locus, A phage clones containing the native and the proviral integration sites (phage clones AC1 and AC3; Fig. 3 ) were digested with various restriction enzymes and hybridized either to the Friend env-specific probe or to probes located immediately adjacent to the F-MuLV provirus (probes B1, B2, and B3; see Fig. 3 ). In addition, the sites of integration and proviral orientation were determined by analyzing total genomic DNA from the cell lines CB3, CB7, TP1, and TP3 with probes corresponding to the Fli-J locus. Normal mouse (BALB/c) DNA yields hybridizing DNA fragments of 3.3 and 2.5. kbp after digestion with BamHI and HindIII, respectively. In addition, another 4.0-kbp BamHI fragment was observed for the CB3 and CB7 cell lines (Fig. 4A, lanes 1 and 2) . Both cell lines also contained a unique 5.6-kbp EcoRI DNA fragment detected with the env-specific probe (Fig. 1, CB3 and CB7 ). These results indicate that both the CB3 and CB7 cell lines contain a F-MuLV provirus integrated in the same transcriptional orientation within a few hundred bases of each other within the Fli-i locus.
A similar analysis of the TP1 and TP3 cell lines, which were independently derived by inoculation of NIH/Swiss mice with F-MuLV (25) , also showed that the Fli-i locus was disrupted by the integration of a F-MuLV provirus. The restriction map of the F-MuLV provirus in the TP1 and TP3 cells revealed an additional HindIII site located 1.2 kbp 3' of the 5' long terminal repeat (33), which is not present in the F-MuLV genome in the CB3 and CB7 cell lines. Based on this analysis, the location and orientation of the F-MuLV proviruses integrated within Fli-i in cell lines TP1 and TP3 is shown in Fig. 3 . This analysis also showed that the F-MuLV provirus integrated within the Fli-i locus of TP1 had the env gene deleted, as no hybridization of the expected DNA fragments was observed with the env probe.
In summary, the restriction enzyme and Southern gel analysis of both cloned and total genomic DNA from four Fig. 3 ) for the Fli-I locus. Lanes: 1, CB3; 2, CB7; 3, BALB/c liver; 4, TP3; 5, TP1; 6, NIH 3T3 cell line; 7, DP28-9; 8, DA24-27; 9, DBA/2J liver.
independently derived erythroid cell lines induced by FMuLV revealed the presence of retroviral insertions within 2 kbp of the Fli-i locus. All proviruses analyzed showed the same provirus orientation (Fig. 3) .
To determine whether F-MuLV integration within the Fli-i region is associated with transcriptional activation, we carried out Northern blot analyses of a number of erythroid and nonerythroid tumors by using several probes located within 15 (33) . The (Fig. 5) ; none of the other cell lines showed any evidence for proviral insertions or large scale rearrangement within Fli-i (Fig. 5) . The sizes of the rearranged EcoRV fragments in the five erythroid cell lines were very close to that observed in the CB7 cell line (Fig. 5) , suggesting that the proviral integration sites are all within about a 2-kbp region of the Fli-i locus. Taken together, these data indicate that Fli-i is rearranged in =75% (9/12) of erythroleukemia cell lines induced by FMuLV.
Relationship Between Fli-i and Sfpi-1. Moreau-Gachelin et al. (17) have reported that the Sfpi-i locus is rearranged by SFFV-P insertion in 95% of erythroleukemia tumors established from the spleens of mice infected with either FV-A or FV-P. To determine the relationship between Fli-i and Sfpi-I, we analyzed DNA from F-MuLV-and FV-induced erythroleukemia cell lines for rearrangements of these two loci. As described above, no rearrangements of Fli-i were observed in 35 cell lines induced by either FV-A or FV-P (Fig. 2) .
Similarly, the Sfpi-J locus showed no evidence of rearrangements in the four cell lines CB3, CB7, TP1, and TP3 induced by F-MuLV (Fig. 6, lanes 1-4) . In agreement with earlier results (17) , six of seven cell lines induced by FV-A or FV-P and isolated in our laboratory clearly showed rearrangements of the Sfpi-J locus after digestion of their DNA with EcoRV (lanes 5-11). These results suggest that Fli-i is distinct from the previously described locus, Sfpi-1, or is at least 25 kbp away from Sfpi-i. Fli-1 Is Located on Mouse Chromosome 9. The chromosomal location of the Fli-i locus was determined by following its strain distribution pattern in recombinant inbred (RI) mouse strains derived from matings between C57BL/6J (B) and DBA/2J (D) mice. The flanking sequence probe B2 detected bands of 25 and 6.7 kbp in DNA from the B and D strains, respectively. DNAs from 26 RI mice were analyzed to determine the strain distribution pattern of the Fli-i locus by using the B2 probe. The experiments revealed a 100% cosegregation pattern between Fli-i and both lap-i and c-ets-i, two genes that have previously been localized to mouse chromosome 9 (Table 1) . These data place Fli-i within 0-2 centimorgans of both the lap-i and c-ets-i loci. 
DISCUSSION
In this study, we have identified and molecularly cloned a region of the mouse genome that is rearranged by retroviral insertions in -75% (9/12) of erythroleukemia cell lines derived from the spleens of mice infected at birth with F-MuLV. This locus, which we have named Fli-i, appears to define a locus that is involved specifically in erythroid leukemias induced by F-MuLV. No rearrangements of the Fli-i region were found in nonerythroid hematopoietic neoplasms induced by F-MuLV, nor was Fli-i rearranged in cell lines isolated from mice inoculated with the FV-A-or FV-P-inducing variants of Friend virus. Although we have not found RNA transcripts by using probes located near the sites of proviral integration within Fli-i, the very high frequency of such integration events, together with the tight association between Fli-i and F-MuLV-induced erythroleukemia noted above, strongly suggests that Fli-i defines a cellular oncogene involved in the neoplastic process.
By following the segregation of polymorphic alleles in the Fli-i region of recombinant inbred mice, we were able to localize Fli-i to mouse chromosome 9, tightly linked to the cellular protooncogenes c-ets-i. Because the replication-competent F-MuLV and by the replicationdefective variants of Friend virus. As reported previously (17) and in the present study, the Sfpi-J locus is a very frequent target of insertion by SFFV-P in erythroleukemia cell lines induced by FV-P but not by F-MuLV. In this paper, we show that the Sfpi-J locus is also rearranged in erythroleukemia cell lines induced by the FV-A complex. In contrast, Fli-J is a frequent target for retroviral insertions in erythroid cell lines induced by F-MuLV but not by SFFV. Thus, distinct cellular genes appear to be activated during the progression from the early to the late stages of erythroleukemia induced by these two highly related viruses. The cells within the hematopoietic stem cell hierarchy that serve as targets for leukemic transformation by either F-MuLV or by FV strains of Friend virus are not known. Thus, the differential involvement of Fli-J and Sfpi-J in Friend disease may reflect a difference in target cells, possibly because these loci have different effects on cells at different stages within the erythroid lineage, or because accessibility to retroviral integration changes as the result of alterations in chromatin structure at different stages of erythroid differentiation. It will be of interest to determine whether retroviral insertion into the Fli-J or Sfpi-J loci activates expression of cellular proteins and whether these proteins are structurally or functionally related to each other or to other proteins involved in the malignant process. Our studies have not ruled out the possibility that Fli-J defines a single large domain in the mouse genome and that insertions anywhere within this region activate a common gene (or genes) important to the induction of erythroleukemia.
It is interesting to note that the region of mouse chromosome 9 where Fli-J maps is syntenic with a portion of the long arm of human chromosome 11 (11q23). This region of the human genome has been reported to undergo frequent rearrangements in a variety of solid tumors and leukemias, although the protooncogene c-ets-J, which also maps to chromosomes 11q23 in humans, has not yet been shown to be involved or activated as the result of these rearrangements (36) . It will be of interest to determine whether the human locus corresponding to Fli-J plays any role in those human cancers that have sustained cytogenetically visible alterations involving chromosome 11q23.
